Physician Perspectives 2017: Biosimilar use in IBD

Market: Pharmaceuticals and Healthcare

Global, 54 pages report, published by GlobalData

Report ThumbnailFebruary-2018
Physician Perspectives 2017: Biosimilar use in IBD

Summary

This Physician Perspectives survey focuses on the use of biosimilar anti-TNFs in IBD.

In the next 12 months, nearly half of physicians stated that they would consider switching Remicade patients (in remission) over to biosimilar IFX. A large proportion of physicians reported that their patients have at least occasionally expressed concern (rated >3) over being switched onto a biosimilar anti-TNF from an originator anti-TNF (67%) or be

Read More
  • Table of contents
  • Executive Summary
  • Methodology
  • Survey Results
  • Demographics
  • Appendix
Read More

Please select a license type

Share

Related Products

GlobalDataPhysician Perspectives 2017: Biosimilar use in IBDProduct ThumbnailPhysician Perspectives 2017: Biosimilar use in IBD, Industry ReportProduct #: 1190968
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2019 Global Market Analyst. All Rights Reserved